Právní předpis byl sestaven k datu 01.09.2026.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx xxx 28. xxxxxxxxx 2016
o xxxxxxxxxx xxxxxxx očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2017
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx x o xxxxx některých souvisejících xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx doporučení Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2017:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx b (DTaPHibVHBIPV):
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx méně xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 25 mikrogramů
Haemagglutininum xxxxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (kmen Mahoney)4 40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx typus b xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx xxx xxxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxxxx přibližně 25 xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV)
Diphtheriae anatoxinum xx méně xxx 20 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxx anatoxinum ne xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 mikrogramů
Haemagglutinum xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 D xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X jednotek xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 D jednotek xxxxxxxx4
Xxxxxxxxx tegiminis xxxxxxxxxx X5 10 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx typu b xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ³ 30 mezinárodních xxxxxxxx
Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx jednotek
Pertussis xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 mikrogramů
Pertactinum (69kD) 8 mikrogramů
NEBO
1ba) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx a dávivému xxxxx (acelulární)
|
1 xxxxx (0,5 xx) obsahuje: Xxxxxxxxxxx anatoxinum |
Minimálně 2 XX* (2 Xx) |
|
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 IU* (5 Xx) |
|
Xxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxx xxxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxxxx filamentosum |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxxxxx, typi 2 et 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx |
1,5 xx (0,33 xx xxxxxxx) |
XXXX
1xx) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx obsahem xxxxxxxx
Xxxxxxxxxxx anatoxinum1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 xx méně než 20 mezinárodních xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx antigena:
Pertussis xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 mikrogramů
1 adsorbováno xx hydratovaný xxxxxxxx xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+
x xxxxxxxxxxx xxxxxxx (XXX04) 0,2 xxxxxxxxx AI3+
1c) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
|
Xxxxxxxxxxx anatoxinum |
min. 30 mezinárodních xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxx (PT) |
25 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx |
(XXX) 25 mikrogramů |
|
Pertactinum (69xX) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx xxxxxxxxxx X |
10 xxxxxxxxxx |
|
xxx anatoxino tetanico |
20-40 xxxxxxxxxx |
1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx … min. 40 xxxxxxxxxxxxx xxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 16 xxx x xxxx:
|
Xxxxxxxxx xxxxxxxxx hepatitidis X |
20 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx B x xxxxxx xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B |
10 xxxxxxxxxx |
1x) xxxxxxxx látka xxxxx xxxxxxxxxx, příušnicím a xxxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka pro xxxxxxxx xxxxxxx50 Xxxxxxxxxxx xxxxx attenuatum (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu50 Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx50
1xx) xxxxxxxx látka xxxxx xxxxxx xxxxxxxx obrně x xxxxxxxxxxxx formě:
Virus xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Mahoney) … 40 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (XXX-1) … 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) … 32 xxxxxxxxxxx D xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx pneumoniae xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X,
18X, 19X, 19X, 20, 22X, 23F, 33X … 25 xxxxxxxxxx z xxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxxxxxxxx proti xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 5
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxxx xxxxxxxxxx |
xx xxxx xxx 2 mezinárodní xxxxxxxx |
|
Xxxxxx anatoxinum |
ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxx: |
|
|
Xxxxxxxxx xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 mikrogramů |
|
Virus poliomyelitidis xxxxxxxxxxx: |
|
|
xxxxx 1 (kmen Xxxxxxx) |
40 X jednotek xxxxxxxx |
|
xxxxx 2 (xxxx XXX-1) |
8 X xxxxxxxx xxxxxxxx |
|
xxxxx 3 (kmen Xxxxxxx) |
2 X jednotek xxxxxxxx |
XXXX
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxx xxxxxx |
xxxx xxxx rovno 2 xxxxxxxxxxx jednotky (2 Xx) |
|
Xxxxxxxxx xxxxxx |
xxxx xxxx xxxxx 20 xxxxxxxxxxxxx jednotek (5 Xx) |
|
Xxxxxxxxx xxxxxxxx: |
|
|
&xxxx;&xxxx; Pertusový xxxxxx |
2,5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Fimbrie xxxx 2+3 |
5 mikrogramů |
|
Xxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) |
40 xxxxxxxxxxx X jednotek |
|
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) |
8 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx poliomyelitis xxxx 3 (inaktivovaný) |
32 xxxxxxxxxxx X jednotek |
1m) očkovací xxxxx xxxxx tuberkulóze (XXX vakcína)
1n) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro xxxxx xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (MPL) 50 xxxxxxxxxx v 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx očkování
2a) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 xxxxxxxxxx |
2x) xxxxxxxx xxxxx xxxxx vzteklině
2c) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxxxxxx X xxxxx inactivatum
3b) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx děti:
Virus xxxxxxxxx A inactivatum
V xxxx 2017 x xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx nemocem, xx xxxxx xxxxxxxxxx předpisů, xxxxx xxxxxxxx xxxxxxxxx xxxxxx antigenního xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx očkovacích xxxxx xx Xxxxxx xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, XXX, v. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 390/2016 Sb. xxxxx xxxxxxxxx xxxx 17.12.2016.
Ke xxx xxxxxxxx právní xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem jiných xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační změna xxxxx xxxxxxxxx právního xxxxxxxx.